// App-Quantinova.ai

1290 : Actinomycin D enhanced immunotoxin RG7787 killing of cancer cells

Researchers

Presenter

  • Xiu Fen Liu

Principal Investigators

  • Laiman Xiang

  • Marco Prunotto

  • Gerhard Niederfellner

  • Ira Pastan

Medical Centers

  • CCR, NIH, Bethesda, MD

  • Roche, Basel, Switzerland.

  • Roche, Penzberg, Germany

Locations

  • United States

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gestational trophoblastic neoplasia

  • Pancreatic cancer

  • Rhabdomyosarcoma

  • Ewing's sarcoma

  • Hereditary susceptibility to Wilms tumor 5

  • Mesothelioma

  • Sarcoma

  • Solid malignancies

Biomarkers

  • Tumor necrosis factor

  • Tumor protein p53

Drug/Treatment

  • RG7787

  • TP53

  • SS1P

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved